Still, compounded versions gained traction in 2022 when there were shortages of the drugs, and they are still going strong for a few main reasons: Some people encounter some pretty rough side effects like nausea and diarrhea, so microdosing can be a way to avoid those issues while still reaping some benefits
It was almost a decade after the first approval in T2D, before GLP-analogs picked up a second indication in obesity
10.1002/jcp.25690 J
Please consult, for example, specialized websites or natural science literature before ordering our products online
Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining -cell function and achievement of HbA1c target one year after initiation
Eligibility, treatment recommendations, and prescriptions are determined only after provider evaluation